Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001677455-26-000002

EVP and Chief Legal Officer sold 1,899 shares at $24.62 ($46,753)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Parschauer Karah Herdman EVP and Chief Legal Officer 2026-06-15 Sale 10b5-1 −1,899 $24.62 $46,753 94,462 D: show line 1 in the form
Open-market sales · 1,899 sh · avg $24.62 · $46,753
Loading xslF345X06/ownership.xml…